Cannabis and drug interactions: what you need to know in 2026.

As medical cannabis use grows in Arizona, one of the most common questions I get from patients — and from their other physicians — is about drug interactions. "Can I take this with my other medications? Will it interact with my blood thinner? Is it safe to use with my antidepressant?"

This is the right question to ask. While cannabis is generally well-tolerated and has a wide therapeutic index, it does have real interactions with several common medication classes. This guide walks through the most important ones, with citations to current research.

How cannabis interacts with other drugs

Cannabis (specifically the cannabinoids THC and CBD) can interact with other drugs through two main mechanisms:

1. Cytochrome P450 metabolism

The P450 enzyme system in the liver metabolizes most prescription medications. Both THC and CBD can inhibit or induce specific P450 enzymes (especially CYP3A4, CYP2C9, CYP2D6, and CYP2C19), which can change blood levels of other drugs.

CBD in particular is a potent inhibitor of several P450 enzymes, which can increase blood levels of drugs that are metabolized by those enzymes.

2. Additive pharmacological effects

Even without metabolic interactions, cannabis can amplify the effects of other drugs acting on similar receptors or pathways. The most important: sedation (combined with sedating drugs), blood pressure changes, and serotonin effects.

Drug class-by-class: what to know

Antidepressants (SSRIs, SNRIs, mirtazapine, bupropion)

Risk level: Low to moderate.

SSRIs (Zoloft, Lexapro, Prozac, Celexa) and SNRIs (Effexor, Cymbalta) are commonly co-prescribed with cannabis. Most patients tolerate the combination well, but watch for:

• Increased sedation with THC, especially in the first 2 weeks of use
• Mild mood effects — some patients notice more emotional blunting or, conversely, more anxiety
• Serotonin syndrome risk — extremely rare with cannabis alone, but theoretical when combined with multiple serotonergic drugs (e.g., SSRI + triptan + tramadol)

Recommendation: Cannabis is generally safe to combine with SSRIs/SNRIs. Start with low THC doses (2.5–5mg) and titrate slowly. If you're on a high-dose SSRI plus another serotonergic drug, mention your cannabis use to your prescriber.

Opioids (oxycodone, hydrocodone, morphine, fentanyl, tramadol)

Risk level: Moderate, but generally favorable.

Cannabis and opioids act on different primary receptors but have overlapping effects on pain and sedation. Research consistently shows that cannabis:

• Reduces opioid dose needed for equivalent pain relief (the "opioid-sparing effect")
• Reduces opioid-related side effects (nausea, constipation)
• Does not increase risk of fatal respiratory depression (a key finding — cannabis does not significantly suppress breathing)

However, the combination can amplify sedation, especially with high-dose THC. The main risk is impairment and falls, not overdose.

Recommendation: Cannabis is considered a harm-reduction tool in chronic opioid therapy. Work with both your pain specialist and certifying physician on a coordinated plan. Many patients successfully reduce their opioid dose with cannabis.

Benzodiazepines (Xanax, Klonopin, Ativan, Valium)

Risk level: Moderate to high.

Both benzos and THC are sedating. Combined, they can cause significant impairment, especially with driving or operating machinery. The bigger concern is dependency: long-term benzo + cannabis use can be hard to taper.

Recommendation: If you're on a benzo, the goal is often to taper the benzo over time as cannabis takes over anxiety management. Don't stop benzos cold — work with your prescriber. Use low-dose THC and avoid high-THC products while on benzos.

Sleep medications (zolpidem, eszopiclone, suvorexant)

Risk level: Moderate.

Cannabis and prescription sleep aids both work on GABA systems (cannabis indirectly, z-drugs more directly). Combined use increases sedation and next-day impairment.

Recommendation: Many patients successfully transition from zolpidem to cannabis for sleep. Work with your physician on a taper. CBD-dominant products are less sedating and may be sufficient for some patients.

Blood thinners (warfarin, rivaroxaban, apixaban, clopidogrel)

Risk level: Moderate, requires monitoring.

CBD can inhibit CYP2C9, which metabolizes warfarin (Coumadin). Combined use can increase warfarin levels and INR, raising bleeding risk. Case reports have documented significant INR elevations when CBD is added to warfarin.

CBD can also interact with rivaroxaban and apixaban (CYP3A4 substrates), though the effect is less dramatic. THC can mildly affect platelet function at high doses, but the clinical significance is unclear.

Recommendation: If you're on warfarin, you can still use CBD but need:

• Baseline INR before starting CBD
• INR check 1 week after starting
• Continued monitoring (every 2–4 weeks initially)
• Warfarin dose adjustment as needed (in collaboration with your anticoagulation clinic)
• Avoid very high CBD doses (> 40mg/day) without close monitoring

For DOACs (rivaroxaban, apixaban), the interaction is less significant but still warrants monitoring. Tell your cardiologist or primary care physician about CBD use.

Anti-seizure medications (valproate, carbamazepine, phenytoin, levetiracetam)

Risk level: Variable, often favorable.

Cannabis (especially CBD) is itself an anti-seizure medication. The combination with other anti-epileptic drugs is often additive and beneficial, but requires monitoring:

• CBD + clobazam: well-studied combination; CBD can increase clobazam's active metabolite, sometimes requiring clobazam dose reduction
• CBD + valproate: combination used in real-world epilepsy treatment; liver enzymes should be monitored
• CBD + carbamazepine: generally safe; CBD may mildly increase carbamazepine levels

Recommendation: Always coordinate cannabis use with your neurologist. Don't replace prescription anti-epileptics with cannabis without supervision — abrupt withdrawal of anti-seizure meds can trigger seizures.

Statins (atorvastatin, simvastatin, rosuvastatin)

Risk level: Low to moderate.

CBD can inhibit CYP3A4, which metabolizes atorvastatin (Lipitor) and simvastatin (Zocor). Combined use can increase statin levels and the risk of muscle side effects (myalgia, in rare cases rhabdomyolysis).

Rosuvastatin (Crestor) and pravastatin (Pravachol) are less affected and are safer choices for cannabis-using patients.

Recommendation: If you're on a statin, mention CBD use to your prescriber. Watch for new muscle aches or weakness. Your provider may switch you to rosuvastatin or pravastatin.

Immunosuppressants (tacrolimus, cyclosporine, mycophenolate)

Risk level: High — avoid without close supervision.

CBD strongly inhibits CYP3A4, which metabolizes tacrolimus and cyclosporine. Combined use can dramatically increase immunosuppressant levels, leading to toxicity. This is especially relevant for transplant patients, who may be looking for alternatives to opioids for chronic pain.

Recommendation: If you're on immunosuppressants, do not use CBD without explicit coordination with your transplant team. The risks are real and significant.

Diabetes medications (insulin, metformin, sulfonylureas)

Risk level: Low to moderate.

THC can affect appetite and glucose metabolism. CBD can theoretically affect insulin sensitivity. The main practical concern: cannabis can mask hypoglycemia symptoms (especially the sweating and tremor that signal low blood sugar). For patients on insulin or sulfonylureas, monitor blood glucose more frequently when starting cannabis.

Recommendation: Tell your endocrinologist or primary care physician about cannabis use. Monitor glucose more frequently for the first 2 weeks.

Thyroid medications (levothyroxine)

Risk level: Low.

No significant interaction. Some patients report needing slightly higher doses of levothyroxine when using cannabis regularly, but the effect is minor.

Beta-blockers (metoprolol, propranolol, atenolol)

Risk level: Low.

Both THC and beta-blockers can lower blood pressure. Combined use can occasionally cause orthostatic hypotension (dizziness on standing). This is more relevant for elderly patients or those on multiple blood pressure medications.

Alcohol

Risk level: Moderate to high.

Cannabis and alcohol are commonly used together, but the combination has real risks. THC amplifies alcohol's effects on cognition and motor coordination. Both can suppress REM sleep. Chronic heavy alcohol use increases the breakdown of THC, reducing its effect.

Recommendation: Avoid combining the two in significant amounts. If you do, use low-dose THC and don't drive.

Specific population warnings

Pregnancy and breastfeeding

Contraindicated. THC crosses the placenta and is present in breast milk. ACOG and AAP recommend against cannabis use during pregnancy and breastfeeding, regardless of medical card status. This is a hard line — there is no medical justification that outweighs the risk.

Liver disease

CBD in high doses has been associated with mild liver enzyme elevations. If you have existing liver disease (hepatitis, cirrhosis, NAFLD), start with low CBD doses and monitor liver enzymes.

Bipolar disorder, schizophrenia, psychotic disorders

THC can worsen psychosis and trigger manic episodes in susceptible individuals. Patients with personal or strong family history of psychotic disorders should generally avoid high-THC products. CBD-only products may be appropriate but should be discussed with a psychiatrist.

How to talk to your doctor about cannabis

Despite growing acceptance, many physicians still don't ask about cannabis use. Bring it up yourself, and have the conversation before you start. Here's a script that works:

"I've been thinking about trying medical cannabis for my [condition]. I'm a registered AZ MMJ cardholder [or planning to apply]. Are there any interactions I should know about with my current medications, especially [specific drug]?"

This opens the conversation non-confrontationally and gives your doctor a chance to flag any concerns. If your doctor isn't knowledgeable about cannabis, ask for a referral to a cannabis medicine specialist.

Pharmacist as a resource

Your pharmacist is often the most practical resource for drug interaction questions. They have access to comprehensive interaction databases and can flag any issues with your medication list. Bring your full medication list (including OTC drugs and supplements) to your cannabis consultation.

The bottom line

Cannabis is generally safe with most medications, but a few classes require careful coordination with your prescriber: blood thinners, immunosuppressants, and drugs with a narrow therapeutic index (where small changes in blood level matter).

For most patients, the most important steps are:

1. Tell all your prescribers that you're using (or planning to use) medical cannabis
2. Start low and go slow — begin with the minimum effective dose
3. Watch for any new symptoms, especially in the first 2 weeks
4. Have a plan for monitoring (INR, drug levels, liver enzymes, etc., as relevant)

The risk of most cannabis-drug interactions is far lower than the risks of untreated pain, anxiety, or PTSD. With good communication and reasonable monitoring, cannabis is a valuable addition to many treatment plans.